vTv Therapeutics Financial Overview
vTv Therapeutics's market cap is currently $146.85M. The company's EPS TTM is $-1.08; its P/E ratio is -10.35; vTv Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-1.06. See an overview of income statement, balance sheet, and cash flow financials.
